is an open access journal that publishes high quality research, literature reviews, position papers and practice guidelines, and case studies on all components of cancer immunology and immunotherapy. Impact Factor:10.3 Citescore:17.7 All metrics >> ...
Basic research studies on topics of relevance are also covered. 主要研究方向:医学-HEMATOLOGY血液学;IMMUNOLOGY免疫学;ONCOLOGY肿瘤学;TRANSPLANTATION移植 BRACHYTHERAPY《近距离放射治疗》 国际标准刊号:ISSN 1538-4721;EISSN1873-1449 核心类别:SCIE(2022版), 外文期刊, 投稿网址:editorialmanager.com/br 期刊网址:...
大类:Medicine小类:Cancer ResearchQ146 / 230 80% 大类:Medicine小类:Immunology and AllergyQ148 / 233 79% 大类:Medicine小类:ImmunologyQ150 / 236 79% 名词解释: CiteScore:该指标由Elsevier于2016年提出,指期刊发表的单篇文章平均被引用次数。CiteScorer的计算方式是:例如,某期刊2022年CiteScore的计算方法是...
G.Vidya, inCardiovascular toxicity and therapeutic modalities targeting cardio-oncology, 2022 1Introduction Cancer immunotherapyis one of the rapidly evolving fields in cancer therapeutics.Immunotherapycan be considered as the fifth weapon of cancer therapy joining the ranks of surgery,cytotoxic chemotherapy...
Track 10: Cancer Immunology & Immunotherapy Cancer immunology is the research of interconnection between the cancer cells and immune system, which is a frequent developing field of research that focus to recognize immunodiagnosis, biomarkers in cancer and to develop innovative cancer immunotherapeutic strat...
Immunology 154, 220–229 (2018). Article CAS PubMed PubMed Central Google Scholar Zhao, L. et al. TGR5 deficiency activates antitumor immunity in non-small cell lung cancer via restraining M2 macrophage polarization. Acta Pharm. Sin. B 12, 787–800 (2022). Article CAS PubMed Google ...
Nature Cancer volume 3, pages 911–926 (2022)Cite this article 123k Accesses 396 Citations 490 Altmetric Metrics details Abstract After several decades, therapeutic cancer vaccines now show signs of efficacy and potential to help patients resistant to other standard-of-care immunotherapies, but they...
2022;12(1):47–61. CAS Google Scholar Singh JK, Farnie G, Bundred NJ, Simões BM, Shergill A, Landberg G, et al. Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms. Clin...
Historically, the primary focus of cancer research has been molecular and clinical studies of a few essential pathways and genes. Recent years have seen the rapid accumulation of large-scale cancer omics data catalysed by breakthroughs in high-throughput
Med. 386, 1973–1985 (2022). Article CAS PubMed PubMed Central Google Scholar Shu, C. A. et al. Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial. Lancet Oncol. 21, 786–795 (2020)....